title: Addiction is a Reward Deficit and Stress Surfeit Disorder.
abstract: Drug addiction can be defined by a three-stage cycle - binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation - that involves allostatic changes in the brain reward and stress systems. Two primary sources of reinforcement, positive and negative reinforcement, have been hypothesized to play a role in this allostatic process. The negative emotional state that drives negative reinforcement is hypothesized to derive from dysregulation of key neurochemical elements involved in the brain reward and stress systems. Specific neurochemical elements in these structures include not only decreases in reward system function (within-system opponent processes) but also recruitment of the brain stress systems mediated by corticotropin-releasing factor (CRF) and dynorphin-κ opioid systems in the ventral striatum, extended amygdala, and frontal cortex (both between-system opponent processes). CRF antagonists block anxiety-like responses associated with withdrawal, block increases in reward thresholds produced by withdrawal from drugs of abuse, and block compulsive-like drug taking during extended access. Excessive drug taking also engages the activation of CRF in the medial prefrontal cortex, paralleled by deficits in executive function that may facilitate the transition to compulsive-like responding. Neuropeptide Y, a powerful anti-stress neurotransmitter, has a profile of action on compulsive-like responding for ethanol similar to a CRF1 antagonist. Blockade of the κ opioid system can also block dysphoric-like effects associated with withdrawal from drugs of abuse and block the development of compulsive-like responding during extended access to drugs of abuse, suggesting another powerful brain stress system that contributes to compulsive drug seeking. The loss of reward function and recruitment of brain systems provide a powerful neurochemical basis that drives the compulsivity of addiction.
authors.affiliation: Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute , La Jolla, CA , USA.
authors.forename: George F
authors.initials: GF
authors.lastname: Koob
keywords: compulsive; corticotropin-releasing factor; dynorphin; extended amygdala; opponent process; prefrontal cortex; reward; withdrawal
references.citation: J Pharmacol Exp Ther. 1994 Dec;271(3):1391-8
references.pmid: 7996451
references.citation: Psychopharmacology (Berl). 1985;86(3):274-80
references.pmid: 2994144
references.citation: J Neurosci. 1995 Aug;15(8):5439-47
references.pmid: 7643193
references.citation: Am J Psychiatry. 2007 Aug;164(8):1149-59
references.pmid: 17671276
references.citation: Neuropsychopharmacology. 1991 Jan;4(1):17-26
references.pmid: 2003866
references.citation: Brain Res. 1988 Dec 6;474(2):364-8
references.pmid: 2463060
references.citation: Brain Res Brain Res Rev. 1990 May-Aug;15(2):71-100
references.pmid: 1980834
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2938-42
references.pmid: 16477003
references.citation: J Neurochem. 1999 Sep;73(3):1066-74
references.pmid: 10461896
references.citation: Psychopharmacology (Berl). 2013 Feb;225(3):753-63
references.pmid: 23007601
references.citation: J Pharmacol Exp Ther. 2007 Sep;322(3):1103-9
references.pmid: 17601982
references.citation: Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5880-4
references.pmid: 7597046
references.citation: Pharmacol Ther. 2004 Oct;104(1):47-58
references.pmid: 15500908
references.citation: Brain Res. 1993 Mar 5;605(1):25-32
references.pmid: 8467387
references.citation: Curr Top Behav Neurosci. 2013;13:3-30
references.pmid: 21744309
references.citation: J Clin Invest. 2003 May;111(10):1444-51
references.pmid: 12750391
references.citation: Nature. 2000 Jan 27;403(6768):430-4
references.pmid: 10667795
references.citation: J Pharmacol Exp Ther. 1994 Oct;271(1):542-8
references.pmid: 7965754
references.citation: Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18156-61
references.pmid: 23071333
references.citation: Alcohol Clin Exp Res. 2009 Mar;33(3):455-63
references.pmid: 19120055
references.citation: J Neurosci. 2004 Apr 7;24(14):3471-9
references.pmid: 15071094
references.citation: Psychopharmacology (Berl). 2009 Sep;206(1):109-20
references.pmid: 19513697
references.citation: J Pharmacol Exp Ther. 2007 Dec;323(3):838-45
references.pmid: 17823306
references.citation: Pharmacol Biochem Behav. 2004 Feb;77(2):405-13
references.pmid: 14751471
references.citation: Alcohol Clin Exp Res. 2002 Oct;26(10):1494-501
references.pmid: 12394282
references.citation: Nat Neurosci. 2002 Jul;5(7):625-6
references.pmid: 12055635
references.citation: Neuropsychopharmacology. 2013 May;38(6):976-84
references.pmid: 23303056
references.citation: Behav Brain Res. 2005 Jun 3;161(1):133-40
references.pmid: 15904720
references.citation: Psychopharmacology (Berl). 1999 Oct;146(3):303-12
references.pmid: 10541731
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):863-9
references.pmid: 18281138
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17198-203
references.pmid: 17921249
references.citation: Psychopharmacology (Berl). 2009 Sep;205(4):565-75
references.pmid: 19484223
references.citation: Neuropsychopharmacology. 2000 Feb;22(2):108-24
references.pmid: 10649824
references.citation: J Neurophysiol. 2001 Mar;85(3):1153-8
references.pmid: 11247984
references.citation: J Pharmacol Exp Ther. 1995 Sep;274(3):1182-91
references.pmid: 7562486
references.citation: Psychopharmacology (Berl). 2000 Nov;152(4):440-6
references.pmid: 11140337
references.citation: J Pharmacol Exp Ther. 2000 Jun;293(3):799-806
references.pmid: 10869378
references.citation: Psychopharmacology (Berl). 2006 May;186(1):48-53
references.pmid: 16552556
references.citation: Mol Pharmacol. 2010 May;77(5):864-73
references.pmid: 20159948
references.citation: J Neurosci. 2006 May 31;26(22):5894-900
references.pmid: 16738231
references.citation: Alcohol. 2003 Feb;29(2):55-60
references.pmid: 12782246
references.citation: Neurosci Lett. 1976 Jul;2(5):295-300
references.pmid: 19604774
references.citation: Behav Brain Res. 2011 Sep 23;222(2):332-41
references.pmid: 21497168
references.citation: Science. 1998 Oct 9;282(5387):298-300
references.pmid: 9765157
references.citation: Science. 1998 Dec 18;282(5397):2272-5
references.pmid: 9856954
references.citation: Addict Biol. 2009 Apr;14(2):130-43
references.pmid: 19291009
references.citation: J Neurosci. 2012 May 30;32(22):7563-71
references.pmid: 22649234
references.citation: Science. 1988 Nov 4;242(4879):715-23
references.pmid: 2903550
references.citation: Neuropsychopharmacology. 2005 Sep;30(9):1662-9
references.pmid: 15726114
references.citation: Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7966-9
references.pmid: 8367449
references.citation: J Pharmacol Exp Ther. 2010 Jan;332(1):298-307
references.pmid: 19843974
references.citation: Psychopharmacology (Berl). 2011 Nov;218(1):257-69
references.pmid: 21468623
references.citation: Neuroscience. 1990;37(3):767-73
references.pmid: 2247222
references.citation: Psychopharmacology (Berl). 2012 Aug;222(4):565-77
references.pmid: 22367168
references.citation: Neuropsychopharmacology. 2005 Jan;30(1):90-8
references.pmid: 15138444
references.citation: Brain Res. 1977 Nov 25;137(1):109-26
references.pmid: 303535
references.citation: Alcohol Clin Exp Res. 2000 Dec;24(12):1836-49
references.pmid: 11141043
references.citation: Alcohol. 2006 May;39(1):21-8
references.pmid: 16938626
references.citation: Eur Neuropsychopharmacol. 2003 Dec;13(6):442-52
references.pmid: 14636960
references.citation: Science. 1982 Dec 10;218(4577):1134-6
references.pmid: 6128790
references.citation: J Neurosci. 2007 Mar 7;27(10):2718-26
references.pmid: 17344409
references.citation: Psychopharmacology (Berl). 2007 Apr;191(3):461-82
references.pmid: 17225164
references.citation: J Neurochem. 2000 Jan;74(1):199-208
references.pmid: 10617121
references.citation: FASEB J. 2002 Jan;16(1):27-35
references.pmid: 11772933
references.citation: Brain Res. 2001 Jun 1;902(2):135-42
references.pmid: 11384606
references.citation: Psychopharmacology (Berl). 2008 Sep;200(1):59-70
references.pmid: 18575850
references.citation: Neuron. 2008 Jul 10;59(1):11-34
references.pmid: 18614026
references.citation: J Neurosci. 2008 Jan 9;28(2):407-14
references.pmid: 18184783
references.citation: Neuropsychopharmacology. 2006 Jun;31(6):1241-8
references.pmid: 16123746
references.citation: Pharmacol Biochem Behav. 2004 Dec;79(4):671-89
references.pmid: 15582675
references.citation: Psychopharmacology (Berl). 2011 Sep;217(2):153-66
references.pmid: 21494791
references.citation: J Neurochem. 1993 Nov;61(5):1620-5
references.pmid: 8228981
references.citation: Am Psychol. 1980 Aug;35(8):691-712
references.pmid: 7416563
references.citation: Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18649-54
references.pmid: 16339307
references.citation: Behav Brain Res. 2008 Dec 1;194(1):39-43
references.pmid: 18639589
references.citation: Peptides. 2009 Apr;30(4):721-6
references.pmid: 19063928
references.citation: Nature. 1976 Nov 4;264(5581):57-9
references.pmid: 12471
references.citation: Brain Res. 2004 Jan 2;995(1):46-54
references.pmid: 14644470
references.citation: Addict Biol. 2012 Jan;17(1):76-85
references.pmid: 21309953
references.citation: Nat Neurosci. 2005 Nov;8(11):1445-9
references.pmid: 16251986
references.citation: Biol Psychiatry. 2011 Jun 1;69(11):1091-9
references.pmid: 21459365
references.citation: J Pharmacol Exp Ther. 2007 Nov;323(2):525-33
references.pmid: 17702903
references.citation: Pharmacol Biochem Behav. 2008 Sep;90(3):475-80
references.pmid: 18501411
references.citation: Neurosci Biobehav Rev. 2004 Jan;27(8):827-39
references.pmid: 15019432
references.citation: Eur J Neurosci. 1999 Aug;11(8):2731-6
references.pmid: 10457169
references.citation: Psychopharmacology (Berl). 2003 May;167(3):251-6
references.pmid: 12669178
references.citation: Behav Brain Res. 1991 Dec 13;46(1):43-8
references.pmid: 1664727
references.citation: J Neurosci. 2006 Nov 1;26(44):11324-32
references.pmid: 17079660
references.citation: Science. 2004 Aug 13;305(5686):1017-9
references.pmid: 15310907
references.citation: Trends Pharmacol Sci. 2004 Apr;25(4):210-8
references.pmid: 15063085
references.citation: Mol Psychiatry. 2013 Mar;18(3):308-19
references.pmid: 22290119
references.citation: Neuropsychopharmacology. 2008 Nov;33(12):2969-80
references.pmid: 18305460
references.citation: Neuropeptides. 2008 Jun;42(3):215-27
references.pmid: 18468678
references.citation: Behav Brain Res. 2010 Jul 11;210(2):288-91
references.pmid: 20193713
references.citation: Neuroreport. 2004 Jun 28;15(9):1479-81
references.pmid: 15194878
references.citation: Adv Exp Med Biol. 1991;295:1-42
references.pmid: 1776564
references.citation: Neuroscientist. 2004 Jun;10(3):221-34
references.pmid: 15155061
references.citation: Brain Res. 1999 Nov 27;848(1-2):141-52
references.pmid: 10612706
references.citation: Neuroreport. 2003 Dec 2;14(17):2229-32
references.pmid: 14625453
references.citation: Alcohol Clin Exp Res. 2004 Nov;28(11):1676-82
references.pmid: 15547454
references.citation: J Neurochem. 1997 Jul;69(1):126-30
references.pmid: 9202302
references.citation: Neuropsychopharmacology. 2012 Jun;37(7):1612-9
references.pmid: 22334124
references.citation: Biol Psychiatry. 2010 May 1;67(9):831-9
references.pmid: 20060104
references.citation: Addiction. 2006 Sep;101 Suppl 1:23-30
references.pmid: 16930158
references.citation: Pharmacol Biochem Behav. 2008 Feb;88(4):497-510
references.pmid: 18031798
references.citation: Neuropharmacology. 2012 Jan;62(1):167-76
references.pmid: 21736885
references.citation: Psychopharmacology (Berl). 2004 Aug;175(1):26-36
references.pmid: 15042275
references.citation: J Pharmacol Exp Ther. 1984 Apr;229(1):127-31
references.pmid: 6323684
references.citation: Neuropsychopharmacology. 2009 Jun;34(7):1743-52
references.pmid: 19145226
references.citation: Psychopharmacology (Berl). 2008 Feb;196(3):473-82
references.pmid: 17965976
references.citation: J Comp Physiol Psychol. 1954 Dec;47(6):419-27
references.pmid: 13233369
references.citation: Alcohol Clin Exp Res. 2007 Jan;31(1):11-8
references.pmid: 17207096
references.citation: Psychopharmacology (Berl). 2004 Apr;172(4):463-70
references.pmid: 14727002
references.citation: Curr Opin Neurobiol. 2013 Aug;23(4):559-63
references.pmid: 23628232
references.citation: J Neurosci. 2001 Sep 15;21(18):7397-403
references.pmid: 11549750
references.citation: Pharmacol Biochem Behav. 2004 Sep;79(1):101-8
references.pmid: 15388289
references.citation: Neuropsychopharmacology. 2000 Apr;22(4):413-21
references.pmid: 10700660
references.citation: J Comp Neurol. 1986 Jul 15;249(3):293-336
references.pmid: 2874159
references.citation: Nat Rev Neurosci. 2001 Feb;2(2):119-28
references.pmid: 11252991
references.citation: Alcohol Clin Exp Res. 2007 Sep;31(9):1473-81
references.pmid: 17624999
references.citation: Ann N Y Acad Sci. 1999 Jun 29;877:486-98
references.pmid: 10415666
references.citation: Pharmacol Rev. 2001 Jun;53(2):209-43
references.pmid: 11356984
references.citation: J Neurosci. 2013 Dec 4;33(49):19384-92
references.pmid: 24305833
references.citation: Pain Med. 2010 Jul;11(7):1092-8
references.pmid: 20545871
references.citation: Psychol Rev. 1974 Mar;81(2):119-45
references.pmid: 4817611
references.citation: Neuroendocrinology. 1983;36(3):165-86
references.pmid: 6601247
references.citation: Science. 1996 Sep 13;273(5281):1561-4
references.pmid: 8703220
references.citation: Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19168-73
references.pmid: 19864633
references.citation: Alcohol. 2004 Feb;32(2):101-11
references.pmid: 15163561
references.citation: Psychopharmacology (Berl). 1991;103(2):227-32
references.pmid: 2027923
references.citation: Fed Proc. 1979 Oct;38(11):2473-6
references.pmid: 488370
references.citation: Psychopharmacology (Berl). 2007 Sep;194(1):127-37
references.pmid: 17514480
references.citation: Psychopharmacology (Berl). 2007 Apr;191(3):433-7
references.pmid: 16977476
references.citation: Neuropsychopharmacology. 2001 Feb;24(2):97-129
references.pmid: 11120394
references.citation: Behav Pharmacol. 1995 Jan;6(1):74-80
references.pmid: 11224314
references.citation: Nature. 1999 Mar 4;398(6722):67-9
references.pmid: 10078530
references.citation: Addict Biol. 2011 Jan;16(1):116-9
references.pmid: 20579007
references.citation: Nature. 2012 Oct 18;490(7420):402-6
references.pmid: 22992525
references.citation: Biol Psychiatry. 2007 Jan 1;61(1):78-86
references.pmid: 16876134
references.citation: Harv Rev Psychiatry. 1997 Jan-Feb;4(5):231-44
references.pmid: 9385000
references.citation: Neuropharmacology. 2009;56 Suppl 1:18-31
references.pmid: 18725236
references.citation: Science. 2004 Aug 13;305(5686):1014-7
references.pmid: 15310906
references.citation: Science. 1982 Jan 22;215(4531):413-5
references.pmid: 6120570
references.citation: Synapse. 2012 Sep;66(9):840-3
references.pmid: 22544368
references.citation: Brain Res. 1995 Mar 27;675(1-2):89-97
references.pmid: 7796157
references.citation: Psychopharmacology (Berl). 2010 Jun;210(2):121-35
references.pmid: 20352414
references.citation: Behav Neural Biol. 1979 Oct;27(2):125-45
references.pmid: 508212
references.citation: Neuropsychopharmacology. 2008 Sep;33(10):2474-82
references.pmid: 18033234
references.citation: Neuropsychopharmacology. 2006 Mar;31(3):563-71
references.pmid: 16034440
references.citation: J Pharmacol Exp Ther. 1995 Feb;272(2):781-5
references.pmid: 7853194
references.citation: Neuropsychopharmacology. 2007 Apr;32(4):955-63
references.pmid: 16943772
references.citation: J Neurosci. 2003 Jul 2;23(13):5674-83
references.pmid: 12843270
references.citation: Pharmacol Ther. 2007 Nov;116(2):306-21
references.pmid: 17868902
references.citation: Neuropeptides. 2000 Jun-Aug;34(3-4):167-72
references.pmid: 11021976
references.citation: Brain. 2007 May;130(Pt 5):1330-7
references.pmid: 17405766
references.citation: Physiol Rev. 1991 Jan;71(1):155-234
references.pmid: 1986388
references.citation: Neurobiol Dis. 1998 Dec;5(6 Pt B):502-33
references.pmid: 9974181
references.citation: Nature. 1998 May 7;393(6680):76-9
references.pmid: 9590692
references.citation: Brain Res. 2010 Feb 16;1314:56-73
references.pmid: 19782055
references.citation: Eur J Neurosci. 2003 Jan;17(1):191-5
references.pmid: 12534985
references.citation: Science. 1997 Oct 3;278(5335):52-8
references.pmid: 9311926
references.citation: Nature. 2001 May 31;411(6837):583-7
references.pmid: 11385572
references.citation: Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
references.pmid: 8401595
references.citation: J Pharmacol Exp Ther. 2003 Apr;305(1):323-30
references.pmid: 12649385
references.citation: Proc Soc Exp Biol Med. 1997 May;215(1):1-10
references.pmid: 9142133
references.citation: Neuropharmacology. 2011 Jul-Aug;61(1-2):35-42
references.pmid: 21338616
references.citation: Future Neurol. 2010 May 1;5(3):393-401
references.pmid: 20563312
references.citation: Psychopharmacology (Berl). 1999 Jul;145(1):21-30
references.pmid: 10445369
references.citation: Neuropsychopharmacology. 2010 Aug;35(9):1932-42
references.pmid: 20445500
references.citation: Pharmacol Biochem Behav. 2011 Jun;98(4):570-4
references.pmid: 21406200
references.citation: Pharmacol Biochem Behav. 2002 May;72(1-2):213-20
references.pmid: 11900791
references.citation: Eur Neuropsychopharmacol. 2008 Apr;18(4):303-11
references.pmid: 17920248
references.citation: Neuropsychopharmacology. 2012 Aug;37(9):2153-60
references.pmid: 22549121
references.citation: Neurosci Biobehav Rev. 2005;29(4-5):829-41
references.pmid: 15893820
references.citation: Behav Neurosci. 2006 Aug;120(4):888-904
references.pmid: 16893295
references.citation: Alcohol Clin Exp Res. 2005 Apr;29(4):584-90
references.pmid: 15834223
references.citation: Trends Neurosci. 2007 Aug;30(8):399-406
references.pmid: 17629579
references.citation: Neuropeptides. 2004 Aug;38(4):213-24
references.pmid: 15337373
references.citation: Neuropsychopharmacology. 2007 Oct;32(10):2238-47
references.pmid: 17327886
references.citation: Alcohol Clin Exp Res. 2003 May;27(5):787-94
references.pmid: 12766623
references.citation: Neuropharmacology. 2011 Dec;61(7):1070-87
references.pmid: 21669214
references.citation: Science. 1986 Aug 15;233(4765):774-6
references.pmid: 3016896
references.citation: Pharmacol Biochem Behav. 2013 Apr;105:151-6
references.pmid: 23454535
references.citation: Neuroscience. 2008 Jul 31;155(1):1-6
references.pmid: 18590801